Phase Transfer Catalysis for Pleuromutilin Derivative Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for preparing pleuromutilin derivatives, such as mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate, face inefficiencies in yield and require chromatography for purification, limiting their practical application in medical therapy, particularly antibacterial therapy.

Innovation Solution

A novel phase transfer catalysis process is employed to synthesize pleuromutilin derivatives, eliminating the need for chromatography and improving yield by reacting a compound with a thiol in a phase transfer catalysis system, which includes using a quaternary ammonium salt and adjusting the pH with an inorganic base.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional methods (potassium t-butoxide in ethanol or sodium methoxide) are used to prepare mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate, then the reaction can proceed, but the yield is low (17-27%) and chromatography is required for purification

Engineering Contradiction:
ImproveyieldVSAvoidpurification process complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention changes the reaction parameters by introducing a phase transfer catalyst (quaternary ammonium salt) and adjusting pH with inorganic base, which fundamentally alters the reaction mechanism to proceed via phase transfer catalysis. This parameter change enables the reaction to achieve high yield (over 70%) without requiring chromatography for purification, directly resolving the contradiction between low yield and complex purification processes

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The quaternary ammonium salt acts as an intermediary catalyst in the phase transfer catalysis system. It facilitates the reaction between the pleuromutilin derivative and thiol by transferring the thiolate ion between phases, enabling the reaction to proceed with high efficiency and yield while avoiding the need for complex purification procedures

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If conventional methods are used, then the synthesis can be completed, but the process is inefficient and requires additional purification steps

Engineering Contradiction:
Improvesynthesis efficiencyVSAvoidprocess time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The phase transfer catalysis system enables continuous and efficient reaction progression without interruption for purification steps. The quaternary ammonium salt catalyst maintains continuous action throughout the reaction, achieving high yield (over 70%) in a single operation, thereby eliminating time loss associated with chromatography and other purification procedures

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This process enhances the yield and efficiency of producing pleuromutilin derivatives, allowing for their effective use in topical antibacterial therapy with improved solubility and stability, specifically in the form of pharmaceutically acceptable salts like hydrosuccinate, hydrofumarate, and tosylate salts.

Implementation Method 1

reacting a compound with a thiol in a phase transfer catalysis system, which includes using a quaternary ammonium salt

Methodology Applied
Scientific EffectPhase transfer catalysis: Catalysis

Implementation Method 2

adjusting the pH with an inorganic base

Methodology Applied
Scientific EffectpH adjustment: Electrolyte

Data Source

PatentUS7875630B2Process salts compositions and use
Publication Date: 2011.01.25 ALMIRALL SA
  • US7875630B2 patent drawing
  • US7875630B2 patent drawing
  • US7875630B2 patent drawing

AI summary

The present invention provides a novel process for preparing pleuromutilin derivatives, novel salts of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate or solvates thereof, novel pharmaceutical compositions or formulations for topical administration comprising mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate or a pharmaceutically acceptable salt or solvate thereof and their use in medical therapy, particularly antibacterial therapy.